L&C Bio Co. Ltd Cash Flow Quality Index
L&C Bio Co. Ltd cash flow quality index. L&C Bio Co. Ltd (290650) has a Cash Flow Quality Index of -0.06x as of December 2024. Operating cash flow of ₩-8.57 Billion is below net income of ₩140.97 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore 290650 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of L&C Bio Co. Ltd (2015–2024)
Cash flow quality index of L&C Bio Co. Ltd from 2015 to 2024. Historical Cash Flow Quality Index for L&C Bio Co. Ltd across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. See 290650 net asset quality score to measure how much of total assets are equity-financed.
L&C Bio Co. Ltd Cash Flow Quality Index by Year (2015–2024)
L&C Bio Co. Ltd cash flow quality index by year from 2015 to 2024. Year-by-year earnings quality comparison for L&C Bio Co. Ltd. For the full cash flow conversion analysis, see 290650 cash flow conversion.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.06x | ₩-8.57 Billion | ₩140.97 Billion | ▲ +75.8% |
| 2023 | -0.25x | ₩-12.13 Billion | ₩48.36 Billion | ▲ +81.2% |
| 2022 | -1.34x | ₩-6.08 Billion | ₩4.54 Billion | ▼ -279.5% |
| 2021 | 0.74x | ₩10.91 Billion | ₩14.65 Billion | ▲ +22.0% |
| 2020 | 0.61x | ₩7.42 Billion | ₩12.15 Billion | ▼ -31.2% |
| 2019 | 0.89x | ₩6.43 Billion | ₩7.25 Billion | ▲ +20.1% |
| 2018 | 0.74x | ₩3.85 Billion | ₩5.21 Billion | ▼ -27.4% |
| 2017 | 1.02x | ₩3.82 Billion | ₩3.75 Billion | ▲ +1187.4% |
| 2016 | -0.09x | ₩-185.35 Million | ₩1.98 Billion | ▲ +91.5% |
| 2015 | -1.10x | ₩-1.33 Billion | ₩1.20 Billion | — |